Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".
New York City has experienced the largest HIV epidemic among persons who use psychoactive drugs. We examined progress in placing HIV seropositive persons who inject drugs (PWID) and HIV seropositive non-injecting drug users (NIDU) onto antiretroviral treatment (ART) in New York City over the last 15 years. We recruited 3511 PWID and 3543 NIDU from persons voluntarily entering drug detoxification and methadone maintenance treatment programs in New York City from 2001 to 2014. HIV prevalence declined significantly among both PWID and NIDU. The percentage who reported receiving ART increased significantly, from approximately 50 % (2001-2005) to approximately 75 % (2012-2014). There were no racial/ethnic disparities in the percentages of HIV seropositive persons who were on ART. Continued improvement in ART uptake and TasP and maintenance of other prevention and care services should lead to an "End of the AIDS Epidemic" for persons who use heroin and cocaine in New York City.
Baron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA. ddesjarlais@chpnet.org.
Don C Des
DC
Jarlais
Baron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Kamyar
K
Arasteh
Baron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Courtney
C
McKnight
Baron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
Jonathan
J
Feelemyer
College of Nursing, New York University, New York, NY, USA.
Holly
H
Hagan
Department of Behavioral Sciences and Health Education, Rolling School of Public Health, Emory University, Atlanta, GA, USA.
Hannah L F
HL
Cooper
Department of Psychiatry, Columbia University, New York, NY, USA.
Aimee N C
AN
Campbell
Department of Psychiatry, Columbia University, New York, NY, USA.
Susan
S
Tross
Baron Edmond de Rothschild Chemical Dependency Institute, Mount Sinai Beth Israel, 160 Water Street FL 24, New York, NY, 10038, USA.
David C
DC
Perlman
D015492:AIDS Serodiagnosis / Q000379:methods / Q000639:trends; D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D055030:Drug Users / Q000706:statistics & numerical data*; D005006:Ethnicity / Q000706:statistics & numerical data; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000208:ethnology; D015528:HIV Seroprevalence / Q000639:trends*; D006306:Health Surveys; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009519:New York City / Q000453:epidemiology; D015995:Prevalence; D044469:Racial Groups / Q000706:statistics & numerical data; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000208:ethnology; D055815:Young Adult
D044966:Anti-Retroviral Agents
Antiretroviral therapy; HIV; Non-injection drug users; Persons who inject drugs; Treatment as prevention